E. Sapey (Birmingham (West Midlands), United Kingdom), S. Aliberti (Milano (MI), Italy)
Late Breaking Abstract - Biofilm formation by Pseudomonas aeruginosa in empyema
J. Liang (Nan ning, China), Z. Zhang (Nan ning, China), J. Li (Nan ning, China), J. Kong (Nan ning, China), W. Ke (Nan ning, China)
|     |
Decreased mortality with rollout of electronic pneumonia clinical decision support across 16 Utah hospital emergency departments
N. Dean (Salt Lake City, Utah, United States of America), C. Vines (Murray, Utah, United States of America), J. Rubin (Murray, Utah, United States of America), B. Webb (Murray, Utah, United States of America), J. Jacobs (Salt Lake City, Utah, United States of America), A. Butler (Salt Lake City, Utah, United States of America), J. Lee (Salt Lake City, Utah, United States of America), A. Jephson (Salt Lake City, Utah, United States of America), N. Jenson (St George, Utah, United States of America), M. Walker (Provo, Utah, United States of America), J. Irvin (Palo Alto, CA, United States of America), M. Lungren (Palo Alto, CA, United States of America), J. Carr (Salt Lake City, Utah, United States of America), R. Srivastava (Salt Lake City, Utah, United States of America), T. Allen (Salt Lake City, UT, United States of America)
| |
The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia
M. Fally (Hellerup, Denmark), S. Israelsen (Copenhagen, Denmark), B. Tarp (Silkeborg, Denmark), T. Benfield (Copenhagen, Denmark), P. Ravn (Hellerup, Denmark)
| |
International Guideline concordance of empiric antibiotic use in community-acquired pneumonia
S. Pascual Guardia (Barcelona, Spain), J. Marin-Corral (Barcelona, Spain), M. Carugati (Milano, Italy), S. Aliberti (Milano, Italy), O. Sibila (Barcelona, Spain), F. Sanz (Valencia, Spain), G. Sotgiu (Sassari, Italy), P. Marcos (A Coruña, Spain), M. Kolditz (Dresden, Germany), M. Restrepo (San Antonio. On behalf of GLIMP investigators., United States of America)
| |
Association of doxycycline and mortality in patients hospitalized with pneumonia
E. Mortensen (Farmington, United States of America), M. Metersky (Farmington, United States of America), A. Anzueto (San Antonio, United States of America)
| |
Methicillin-susceptible Staphylococcus aureus in Community-Acquired Pneumonia: Risk Factors and Outcomes
C. Cilloniz Campos (Barcelona, Spain), C. Dominedò (Roma, Italy), A. Gabarrus (Barcelona, Spain), C. Garcia-Vidal (Barcelona, Spain), E. Moreno (Barcelona, Spain), C. Vargas (Barcelona, Spain), A. Torres (Barcelona, Spain)
| |
PLEURAL EFFUSION IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
J. Andia Iturrate (Barakaldo, Spain), L. Ruiz Iturriaga (Barakaldo, Spain), B. Gonzalez Quero (Barakaldo, Spain), A. Gomez Bonilla (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), B. Ortiz De Urbina Antia (Barakaldo, Spain), S. Castro Quintas (Barakaldo, Spain), A. Rezola Carasusan (Barakaldo, Spain), L. Serrano Fernandez (Barakaldo, Spain), R. Zalacain Jorge (Barakaldo, Spain)
| |
Identification of pleural infection microbiological patterns by applying next generation sequencing and bioinformatics analysis
N. Kanellakis (Oxford, United Kingdom), E. Bedawi (Oxford, United Kingdom), J. Wrightson (Oxford, United Kingdom), J. Corcoran (Oxford, United Kingdom), R. Hallifax (Oxford, United Kingdom), R. Mercer (Oxford, United Kingdom), V. George (Oxford, United Kingdom), R. Banka (Oxford, United Kingdom), M. Jabeen (Oxford, United Kingdom), R. Asciak (Oxford, United Kingdom), R. Miller (London, United Kingdom), N. Maskell (Bristol, United Kingdom), I. Psallidas (Oxford, United Kingdom), T. Hinks (Oxford, United Kingdom), D. Crook (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom)
| |